Klotho/FGF23 and Wnt Signaling as Important Players in the Comorbidities Associated with Chronic Kidney Disease
Fibroblast Growth Factor 23 (FGF23) and Klotho play an essential role in the regulation of mineral metabolism, and both are altered as a consequence of renal failure. FGF23 increases to augment phosphaturia, which prevents phosphate accumulation at the early stages of chronic kidney disease (CKD). T...
Main Authors: | Juan Rafael Muñoz-Castañeda, Cristian Rodelo-Haad, Maria Victoria Pendon-Ruiz de Mier, Alejandro Martin-Malo, Rafael Santamaria, Mariano Rodriguez |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/12/3/185 |
Similar Items
-
Plasmatic Klotho and FGF23 Levels as Biomarkers of CKD-Associated Cardiac Disease in Type 2 Diabetic Patients
by: Ana Paula Silva, et al.
Published: (2019-03-01) -
Klotho/FGF23 axis mediates high phosphate‐induced vascular calcification in vascular smooth muscle cells via Wnt7b/β‐catenin pathway
by: Yan‐Xia Chen, et al.
Published: (2019-07-01) -
FGF23, Biomarker or Target?
by: Cristian Rodelo-Haad, et al.
Published: (2019-03-01) -
Skeletal manifestations in end-stage renal disease patients and relation to FGF23 and Klotho
by: TOMŞA Anamaria Magdalena, et al.
Published: (2020-09-01) -
FGF-23, Klotho and Vitamin D Levels in Scleroderma
by: Ravan AHMADI, et al.
Published: (2017-04-01)